Clinical Trial Update: Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial update studying decitabine and clofarabine in higher risk myelodysplastic syndromes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Clofarabine (clofarabine)
• Decitabine (Decitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-11-15